| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f42cc0824ed5654236b8949bd95c9805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81cff4aabf361c4a8db8b0922f23d9ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c7effdee51407bf92beecac0fe2c8a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065733848f38c29380e68ac18367ec86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83bd6c0854c61bb4d08b59edbcd4c814 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7155 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-20 |
| filingDate |
2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdbf657b0d5e32e52176ab2ef638452d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fec9064819d04f06a4121c586db0667
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54facfd616a82c4f1abd1a4df25296a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20958c52ad0743554290c3a7267aa0d6 |
| publicationDate |
2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017002420-A1 |
| titleOfInvention |
Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder |
| abstract |
This invention relates to the use of human neutrophil marker interleukin 8 receptor B (IL8Rb) for detection of bladder cancer, and more particularly to the use of EL8Rb for discriminating between transitional cell carcinoma of the bladder (TCC) and inflammatory conditions of the bladder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017162176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116024345-A |
| priorityDate |
2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |